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West Nile virus infection is a growing concern in Europe. Vector management is often the primary option to
prevent and control outbreaks of the disease. Its implementation is, however, complex and needs to be supported
by integrated multidisciplinary surveillance systems and to be organized within the framework of predefined
response plans. The impact of the vector control measures depends on multiple factors and the identification of
the best combination of vector control methods is therefore not always straightforward. Therefore, this contribution
aims at critically reviewing the existing vector control methods to prevent and control outbreaks of West Nile virus
infection and to present the challenges for Europe.
Most West Nile virus vector control experiences have been recently developed in the US, where ecological conditions
are different from the EU and vector control is organized under a different regulatory frame. The extrapolation of
information produced in North America to Europe might be limited because of the seemingly different epidemiology
in the European region. Therefore, there is an urgent need to analyse the European experiences of the prevention
and control of outbreaks of West Nile virus infection and to perform robust cost-benefit analysis that can guide the
implementation of the appropriate control measures. Furthermore, to be effective, vector control programs require a
strong organisational backbone relying on a previously defined plan, skilled technicians and operators, appropriate
equipment, and sufficient financial resources. A decision making guide scheme is proposed which may assist in the
process of implementation of vector control measures tailored on specific areas and considering the available
information and possible scenarios.
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West Nile virus (WNV) infection is a viral disease
transmitted by mosquitoes and distributed worldwide.
The virus is primarily maintained in an enzootic cycle
involving a number of wild birds and ornithophilic
mosquito species. When the climatic or environmental
conditions become favourable the virus circulation may
increase and transmission to other susceptible hosts such
as humans and equids may occur. These are considered
dead-end hosts because the viremia remains at a level
not suitable for mosquito infection [1,2]. The vast
majority of human cases remain asymptomatic and severe* Correspondence: rbellini@caa.it
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unless otherwise stated.neuroinvasive illness is reported in less than 1% of infected
people [3,4]. The high number of non-symptomatic cases
may increase the risk of WNV transmission through
blood donation or organ transplants. WNV can be
transported over long distances in migratory birds.
While resting in wetland areas they might come in
contact with the local mosquito species, and possibly
initiate a local amplification cycle. In temperate regions
the virus may overwinter in female mosquitoes as
well as in birds, so there is no need for continuous
re-introductions [5-10].
WNV infection is a growing concern in Europe. The
infection has been documented since the early 1950s in
several countries of the European Union (EU) [11]. In
1996, Romania reported the largest outbreak of WNV
infection in humans to date inside the EU, with over 390td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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breaks in the EU and Balkan countries have been reported
in Albania, Austria, Bosnia and Herzegovina, Bulgaria,
Croatia, Czech Republic, The Former Yugoslav Republic of
Macedonia, France, Greece, Hungary, Italy, Kosovo,
Montenegro, Portugal, Romania, Serbia, and Spain [13-27].
In Europe WNV has been found in several field col-
lected mosquito species, such as Culex pipiens s.l.,
Culex modestus, Culex univittatus, Coquillettidia
richiardii, Aedes cantans, Aedes caspius, Aedes excrucians,
Aedes vexans, Anopheles maculipennis s.s. and Anopheles
atroparvus [11,28-32], but based on the current evidence
the major vector role in outbreaks of WNV infection in
Europe seems to be covered by Cx. pipiens s.l. [12,31,33]
with Cx. modestus playing a role in specific regions [34].
The prevention and control of outbreaks of WNV
infection are complex and need integrated multidisciplinary
surveillance systems and response plans [35]. The integrated
vector management (IVM) is the primary option to prevent
and control outbreaks. The WHO defines IVM as “a
rational decision-making process for the optimal use
of resources for vector control” [36]. IVM is intended to
utilize the best cost-benefit combination of all available
control methods in a sustainable way respecting the envir-
onment in order to reduce the vector density and/or the
vector-human contacts to levels not posing a public health
concern. Yet, the implementation of IVM is hampered by
the complexity of the WNV transmission cycle, the
difficulties in estimating the size of the forthcoming
outbreak in a timely matter and the related risk assessment.
Moreover, the information necessary to make a robust
cost-benefit analysis that guides the implementation of
the appropriate measures is largely missing, as well as
the species-specific WNV vector density thresholds,
and the fact that mosquito control programs mostly rely
on empirical data and past experience. The identification
of the best vector control methods is therefore not always
straightforward. Hence, this contribution aims at reviewing
the existing vector control methods to prevent and control
outbreaks of WNV infection and to present the challenges
in a European context.
Review
The data bases PubMed and Promed were searched
using the key words: West Nile, West Nile control, West
Nile prevention, West Nile and cost benefit, Culex
pipiens, Culex and overwintering, Culex pipiens and
resistance, adulticide, aerial spray, larval control, larval
management, mass trap, overwintering, ULV. The most
important relevant accessible reports and unpublished
documents were consulted and expert colleagues were
contacted to provide additional information.
In the context of the EU WNV and blood safety
preparedness plan an affected area is defined as anarea with at least one case of WNV infection in humans
according to the EU case definition [37]. Assigning an area
as an affected area triggers the implementation of control
measures. Hence this trigger, one case of WNV infection
according to the EU case definition, was used as a
definition of an outbreak in this paper. Prevention of
WNV infection is intended before the occurrence of
equine or human cases, while control of WNV infection is
considered following the occurrence of at least one case of
WNV infection.
Control measures targeting the mosquito larvae
In the context of outbreak prevention of WNV infection
the objective of larval control is to contain immature
stages in order to keep adult mosquito populations at
density levels below which they pose a public health
risk. Unfortunately, insufficient information exists to
establish a larval density threshold that can be used
to guide control operations [38-40]. The role of lar-
val control to contain outbreaks of WNV infection
should be considered as part of an IVM program
(see Vector control decision making process section).
Hence a larval control program must be in place in
the areas known as susceptible to outbreaks of WNV
infection (see Vector control decision making process
section, Table 1).
Environmental management and source reduction
These activities have the important advantage over direct
vector control operations to be long lasting or even
permanent in their effects, thus allowing a positive
cost-benefit balance. To appropriately adopt environmental
management practices field investigations should be
performed in advance to characterize and geo-reference
breeding sites. Skilled technicians should conduct field
inspections to cover at least one whole favourable season,
mapping the potential and active breeding sites, defining
their dimensions, accessibility, mosquito productivity
by species, environmental value taking into account
biodiversity issues especially when dealing with natural
protected areas, seasonal dynamic, and indicating possible
management actions. Source reduction can include simple
activities such as the proper disposal of containers in
backyards and the cleaning of rain gutters by property
owners, to agronomic practices aimed at the reduction
of standing waters, to extensive regional water man-
agement projects on public land. All these activities
eliminate or substantially reduce mosquito breeding
habitats and diminish the need for repeated application of
insecticides [41-52].
Biological larval control
Direct biological larval control includes methods to
enhance the activity of natural antagonists by introducing
Table 1 Overview of the vector control methods currently used for the prevention and control of outbreaks of WNV
infection
Suggested use3
Activities Target environments Products and equipment Prevention Outbreak control
Targeting the mosquito larvae1
Environmental management
and source reduction
artificial wetlands, hunting farms,
lagoons, recreational, rice fields,
irrigation canals, urban environments
Ground equipment, excavators,
mowers, pumps
+++ Part of IVM programme
Chemical Breeding sites as specified in
the insecticide label
According to WHO guidelines
and EU regulations:
++ Part of IVM programme
S-Methoprene, Diflubenzuron,
Pyriproxyfen, Triflumuron
Biological artificial wetlands, lagoons, rice
fields, irrigation canals, urban
environments
Gambusia (where allowed), native
fish species, Macrocyclops
++ Part of IVM programme
Microbial and others wetlands, lagoons, rice fields,
irrigation canals, urban
environments
According to WHO guidelines and
EU regulations
++ Part of IVM programme
Bacillus thuringiensis israelensis,
Bacillus sphaericus, Spinosad
Community participation inhabited areas Insecticide formulations for
domestic use
+ Part of IVM programme
Targeting the adult mosquitoes2




treatments (ULV or LV)











mosquito activity peak in
case of West Nile virus risk
mosquito screen over windows,
space or topical repellents, protective
clothes
+++ +++
1The suggested use of vector control methods targeting the mosquito larvae refers to the impact on the vector population. The impact in reducing the WNV
transmission is not well known; 2The suggested use of vector control methods targeting the adult mosquitoes refers to the impact on WNV transmission; 3+++
highly useful; ++ useful; + potentially useful in some circumstances; - currently no evidence of usefulness.
IVM: integrated Vector management; ULV: Ultra Low Volume.
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allowing natural predators to colonise isolated water
bodies by digging ditches to connect them [53-59].
This approach must be carefully evaluated in terms
of environmental risk and the possible negative im-
pact on biodiversity. Fish species such as Gambusia
spp. are broad range predators and exotic to Europe.
The “Habitats and Birds Directives” contain restric-
tions on the deliberate introductions of alien species
into the wild and rearing and introduction of these
species in water bodies is currently restricted in most
countries. Predacious indigenous copepods such as
Macrocyclops albidus may easily be reared and intro-
duced in artificial containers where they reproduce
and strongly reduce mosquito larval density [60].
They have limitations because they require good
water quality and have been shown to be highly
effective on Aedes, while only relatively effective on
Culex species [58,61].Naturally derived products and microbial larval control
Larval control by industrially produced bacteria is well
developed because of the high efficacy combined with
the selectivity of action which makes these products the
best possible choice in terms of environmental impact.
Several formulations based on Bacillus thuringiensis
israelensis (B.t.i.) and Bacillus sphaericus (B.s.) bacteria
formulations are available on the EU market or in the
process of being marketed in the near future (see
Biocides used in Europe section). The use of these
products is usually allowed even in naturally protected
areas. The main disadvantage is the short lasting activity
which requires repeated applications. When bio-larvicide
applications target large breeding areas (such as rice
fields or wetlands) they may be performed by air
(helicopter or fixed wings) following specific authorizations
in exception of the 2002/2277 EU Parliament resolution.
Relevant resistance phenomena have been evidenced
following intensive utilization of B.s. against Culex species
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Spinosad, derived via fermentation from the naturally
occurring soil actinomycete, Saccharopolyspora spinosa, is
also available in some countries and in the marketing
process in others.
Chemical larval control
Direct larval control using chemical larvicides may be
implemented using different products depending on the
natural values of the target environment. Chemical larval
control can only be done by ground application targeting
previously mapped breeding sites. Four main active
ingredients, all pertaining to the Insect Growth Regulators
(IGRs) category, are currently available or under the
revision process in the EU market: S-Methoprene,
Diflubenzuron, Pyriproxyfen, Triflumuron [65]. Aerial
application is not allowed following the adoption of the
European Parliament resolution: “Towards a thematic
strategy on the sustainable use of pesticides” (2002/2277
(INI)) (see Biocides used in Europe section).
Community participation
Culex control by community participation includes the
elimination of breeding sites and larval control in private
areas and can be part of the environmental management
and source reduction approaches. Regular information
campaigns may be organized targeting the most relevant
citizen groups (e.g. farmers, land owners, scholars) aimed
to promote the adoption of appropriate behaviour. These
basic information campaigns should clearly consider the
messages and the timing to obtain the best possible
efficacy both in situation of possible and already ongoing
outbreaks without losing effectiveness.
Control measures targeting the adult mosquito
In general adult mosquito control operations are aimed
at the prompt reduction of adult mosquito density and
longevity in a defined area in case of an outbreak.
Adult control is not recommended as a routine
method in outbreak prevention of WNV infection because
outbreaks are currently largely unpredictable in time,
space, and size. The environmental toxicity and broad
action spectrum of the available insecticides for mosquito
adult control implies that they can only be used in case of
real need and focused on well-defined target areas. A well
designed and managed active surveillance programme can
be instrumental to define when adulticiding is appropriate
(see Vector control decision making process section,
Table 1). In any case measures of vector control to
stop ongoing outbreaks of WNV infection should be
implemented according to a pre-developed plan established
as a public health measure by the sanitary authority. The
plan should be technically detailed and responsibilities
clearly defined.Adult control
Adult control is considered the most convenient vector
control approach during the outbreak phase because it
has the capacity to promptly reduce infective mosquito
females responsible for vectoring the disease as well as
to reduce the mean longevity and the total reproduction
capacity of local vector populations. The biocides and
their application are strictly regulated by the EU and
WHO provides guidelines on their use for public health
purposes (see Biocides used in Europe section).
The current ground application technology for mosquito
control mainly refers to equipment able to produce
thermal or cold aerosols with particle dimensions of a
defined range. It is considered that for mosquito adult
control the best efficacy in terms of mortality is achieved
when droplet diameter is in the range 5-30 μm (the best
droplet size must be defined more precisely according to
parameters such as formulation type and concentration,
application equipment, environmental condition, habitat
type, target species sensitivity) [66-71]. Ultra Low Volume
(ULV) application is defined as the minimum effective
volume of the formulated product without any further
dilution (0.6-18 l/h). While Low Volume (LV) (18-60 l/h)
and High Volume (HV) (>150 l/h) require the formulation
being diluted before use.
There is no vector density threshold to guide decisions
about the degree of vector population suppression that
must be attained, or for how long this suppression must
be maintained to reduce human disease transmission [38].
Through mathematical modelling it has been suggested
that it would be appropriate to focus the vector control
activities late in the season to target overwintering
mosquitoes when temperatures are dropping [72]. The
practical implications of a vector control program tar-
geting overwintering mosquito females need further
evaluation.
Mass trapping
A number of traps have been developed to attract,
catch and kill large numbers of mosquitoes, thus re-
moving them from the target area. This technology is
developing rapidly and there is considerable variability
in the way these traps function [73,74]. Studies set-up
to determine the real level of protection provided by
these traps in the area they possibly cover showed
low effectiveness [75,76].
Personal protection methods
Personal protection methods from mosquito bites include
the use of space or topical repellents, the installation
of mosquito screens over windows, wearing protective
clothes (such as long sleeves and long pants), the
adoption of preventative behaviour useful to help to
avoid or reduce exposure to mosquito bites (i.e. limit
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and mosquito proof homes. The effectiveness of personal
protection methods in reducing the risk of acquiring
WNV infection has been demonstrated by Loeb et al. [77]
in Ontario, Canada. Between the different available tools
for self-protection, repellents play an important role
as they protect people when outdoors for normal activities.
The most effective repellent substances are: DEET (N,N
Diethyl Toluamide), Picaridin (1-(1methylpropylcarbonyl)-
2-(hydroxyethyl)-piperidine), also known as KBR, and
IR3535. Recently, various essential oils have been pro-
posed as insect repellents, but their protection against
anthropophilic species is considered low [78-82]. A number
of studies have demonstrated that electronic mosquito
repellers are ineffective and that some of them could even
increase the biting frequency of mosquitoes [83,84].
To favour a large adoption of personal protection
methods specific information campaigns must be con-
ducted. These campaigns are not suggested as a routine
preventative method for outbreaks of WNV infection, but
they need to be connected to an active surveillance system
in order to be activated only in case of real risk (see Vector
control decision making process section).
Biocides used in Europe
The biocides that can be used for larval and adult
mosquito control are based on the active ingredients
covered in the review being carried out under the
Biocides Directive 98/8/EC (second phase of the 10-year
work programme referred to in Article 16), Commission
Regulation (EC) No 1451/2007 of 4 December 2007 and
more recently by the Biocides Regulation 528/2012.
The objective of the new Regulation is to improve the
functioning of the EU internal market in biocidal
products whilst ensuring a high level of environmental
and human health protection. Some concerns have been
raised on the possibility that following the procedure few
products will available for vector control thus weakening
our capacity to protect communities from vector-borne
diseases.
WHO through the WHO Pesticide Evaluation Scheme
(WHOPES) collects, consolidates, evaluates and dissemi-
nates information and guidelines on the use of pesticides
for public health. Updated information can be found on
the website (http://www.who.int/whopes/en/).
The organization of mosquito control refers to ground
application as the aerial distribution of toxic insecticides
is strictly forbidden following the European Parliament
resolution 2002/2277. In case of an ongoing large epidemic
there might be an emergency exception under the re-
sponsibility of regional or country authorities. As an
example, in Greece, experimental aerial treatments
using a helicopter equipped with ULV nozzles to spray
pyrethroids (Deltamethrin and D-Phenothrin) againstmosquitoes have been recently conducted during the
outbreak of WNV infection [85].
For mosquito larval control five active ingredients are
currently available or under the revision process, namely
S-Methoprene, Diflubenzuron, Pyriproxyfen, Triflumuron,
Spinosad [65]. Several formulations of microbial larvicides
based on Bacillus thuringiensis israelensis are available on
the EU market (liquid, powder, granular, briquette) [86].
Bacillus sphaericus formulations are present in some
countries (i.e. France, Germany), while in the process of
being marketed in the near future in other countries.
The main active ingredients for adult control belong to
the pyrethrin and pyrethroids group. These compounds
have good safety margins in terms of acute toxicity for
warm blooded animals but are toxic for non target insect
species and aquatic organisms [87-90]. Possible long term
effects and cumulative effects are much more complex to
establish.
Impact and cost-benefit of vector management on WNV
transmission
Available data on the impact of vector control on WNV
transmission is available from the USA showing both
failures and successes (summarised in Table 2), while
documented examples for Europe are not available. In
general, single application for adult control has been
shown to have a transient effect and, in the event of
an epidemic, multiple sequential treatments may be
required to decrease vector abundance to a level that
will stop transmission [Table 2 and [91,92]]. As a
general opinion shared by US colleagues repeated aerial
treatments seem to be more effective in reducing WNV
circulation than ground application because the capacity
to rapidly cover large areas. Effective surveillance must be
maintained during vector control activities to determine if
and when re-treatment is required to maintain suppres-
sion of the vector populations. Vegetation may have a
negative effect on ULV treatment efficacy by filtering the
aerosol leading to a reduction in the amount of pesticide
available to impact the mosquito, and by reducing wind
speed in the canopy thus reducing aerosol dispersion.
Considering the efficacy of personal protection measures
in reducing the risk of acquiring WNV infection Loeb [77],
working in Ontario, Canada, demonstrated that the
adoption of ≥ 2 personal protective behaviour attitude
(such as avoidance of exposure to mosquitoes, wearing
long sleeves and pants, using mosquito repellent) reduced
the risk of WNV infection by half. Averett et al. [102]
evaluated the 2003 WNV public education campaign in
Kansas. Even if the campaign achieved widespread
awareness among the public, people’s compliance to use
protective measures was low most probably because of a
low risk perception of WNV infection. The messages were
most effectively delivered through television, newspapers
Table 2 Examples from the USA on the use of adult mosquito management in the control of outbreaks of WNV infection
Study Observed efficacy Reference
Louisiana This study calculated an 86% decrease (compared with a 5-year average) in WNV mosquito vector species in 2002 resulting
from increasing control efforts (aerial and ground ULV with Naled (1,2-dibromo-2,2-dichloroethyl dimethyl phosphate) over
a 4-month period in St. Tammany Parish, Louisiana.
[93]
Florida This study estimated a seasonal mean 64.1% Culex nigripalpus density reduction following emergency aerial sprays with
Naled in 26 Florida counties during 2004, in response to several hurricanes.
[94]
Boston Poor efficacy of ground ULV treatments with Resmethrin against Cx. pipiens and Cx. restuans in the Boston area showed
that the aerosol plume delivered from the road failed to contact the target mosquitoes because it was blocked by the
vegetation. Therefore, the application was unable to reduce transmission of WNV.
[95]
Kentucky The University of Kentucky evaluated the efficacy of professional application of bifenthrin and lambda-cyhalothrin as barrier
treatments with backpack mist blower directed to all vegetative surfaces up to the height of 3 m. Residual efficacy in reducing
adult mosquito populations was studied at 24 residential properties (eight replications by three treatments). Mosquito populations
were measured on each property by using five methods: CO2-baited CDC light traps (without a light), human landing rates, CDC
gravid traps, ovitraps, and sweep nets. Populations were monitored weekly for two weeks before treatment and eight weeks
post-treatment. Additionally, to confirm residual efficacy of each insecticide, a randomly treated leaf underwent a no-choice
bioassay with laboratory-reared Ae. albopictus. Trap collections indicate Ae. albopictus and Cx. pipiens as the most abundant
species in the area. Both insecticides significantly reduced Ae. albopictus density in comparison with the untreated control areas
(85.1-89.5% reduction), and Ae. albopictus bioassay showed significant residual efficacy for both insecticides up to six weeks
post-treatment. In contrast, Culex spp. were not reduced by either insecticides. The study seems to therefore indicate that barrier
sprays applied to low-lying vegetation do not properly target adult daytime resting sites for Culex mosquitoes but that they can
reduce Aedes mosquitoes. Perhaps Culex spp. abundance may be reduced by treating upper tree canopies.
[96]
California In California, in 2004-2005, a program was implemented to control the amplification and dispersal of WNV using sequential
ground ULV applications of Pyrenone® 25-5 (Insecticide containing Pyrethrins (5.0%) and Piperonyl Butoxide (25.0%)). Local
treatments were started one month after the initial detection. Evaluations indicated that while the treatments were effective
in reducing vector abundance, they had little effect on virus transmission, and WNV was dispersing throughout the area.
[97]
Sacramento Carney et al. determined the efficacy of the aerial treatments with pyrethrins combined with piperonyl butoxide (PBO) on
WNV transmission in Sacramento county during the 2005 epidemic. No human cases occurred in the treated area after
repeated treatments (number of treatments not specified), compared with 18 cases in the untreated area. Consequently,
they considered the emergency aerial spray to be effective in reducing both mosquito populations and WNV cases.
[98]
California In the Coachella Valley good results were achieved with early season treatment in mid-April immediately following the first
detection of WNV.
[99]
California In Sacramento County, an aerial distribution of Evergreen EC 60-6 (insecticide containing Pyrethrins (6.00%) and Piperonyl
butoxide (60.00%)) over approximately 215 km2 obtained a significant decrease in the abundance of both Cx. tarsalis and
Cx. pipiens, as shown by pre- and post-trapping realized inside and outside the spray zone.
[100]
New York Controlling mosquito populations at the end of the season, before Culex females enter refuges, appeared to be an effective
way to force declines in the virus circulation
[72]
California This study examined the efficacy of the 2005 emergency aerial spray in Sacramento County, which used pyrethrins to
control adult mosquitoes. An unsprayed area within the county was used as the control, showing a total decrease in Cx.
pipiens and Cx. tarsalis, of 57.5%, compared with the pre-spray population in the treated area. They also observed a decrease
in WNV infection rates in collected mosquitoes from 6.7/1,000 in the untreated areas to 3.9/1,000 in the treated areas.
[101]
Illinois In the 2005 the city of Chicago used ground ULV treatments of sumithrin (ANVIL 10 + 10 at the dose of 1.36 g/ha), in areas
with high WNV infection rates among Culex mosquitoes (>5 infected mosquitoes/1000). Gravid traps at 87 sites were used
for monitoring. Two sequential treatments in weeks 31 and 32 decreased mean mosquito density by 54% (from 2.5 to 1.1
mosquitoes per trap-day), whereas mosquito density increased from 1.3 to 3.3 mosquitoes per trap-day at the non-sprayed
sites. The difference between these changes in mosquito density was statistically significant. While other two sequential
adulticide treatments in weeks 34 and 35 had no effect on mosquito density (probably because it was late in the season
and the mosquitoes were presumably entering diapause and less active). Overall, there was significant decrease in mosquito
density at the trap sites treated in all 4 weeks (weeks 31, 32, 34, and 35), while no significant effect was observed following
single applications. Maximum likelihood estimates (MLE) of infection rate estimates varied independently of adulticide treatments,
suggesting that the adulticide treatments had no direct effect on MLE. In general gravid trap counts were very low, which was
probably due to large numbers of alternative oviposition sites, especially catch basins competing with the gravid traps.
[92]
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healthcare providers, veterinarians, magazines, and the
internet were less successful. Brochures were least
successful, indicating that they may be ineffective for
this type of communication. None-native English
speakers were less informed than native ones.
A cost-effectiveness analysis of vector control generically
starts from a problem and presuppose an analysis of costsand effectiveness of each alternative solution [103]. The lit-
tle scientific information focused on cost-benefit analysis in
vector control targeted to WNV transmission comes from
the US, following the large WNV epidemic the country
experienced from 1999. The impact of WNV infection in
the US was large, reaching a peak in the 2003 when 9,862
human cases (264 deaths) were registered (http://www.cdc.
gov/ncidod/dvbid/westnile/surv&control_archive.htm).
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the outbreak of WNV infection in 2002 in Louisiana,
which resulted in 329 cases with 24 deaths. They consid-
ered the period June 2002-February 2003 (therefore long
term costs were not considered), and included costs related
to total medical care, productivity loss, public health
department state activities, and vector control. Total
epidemic costs were estimated as ≈ 20.14 million$
(including 9.2 million$ for mosquito control and public
health agency costs) equal to 61,215 $/case. In 2005, an
outbreak of WNV infection occurred in Sacramento
County, California, where 163 human cases were reported.
In response to WNV surveillance indicating increased
WNV activity, the Sacramento-Yolo Mosquito and Vector
Control District conducted an emergency aerial spray by
pyrethrins for six nights on an area of ≈ 477 km2. The
economic impact of the outbreak (including medical
cost to treat cases and patients’ productivity loss) has been
estimated as ≈ $2.28 million (equal to 13,987 $/case).
Vector control cost was estimated as ≈ $701,790. A
cost-benefit analysis indicated that only 15 cases of WNV
neuroinvasive disease would need to be prevented to make
the emergency spray cost-effective [105].
Vector control decision making process
Prevention and control of WNV infection should be
based on an integrated preparedness plan taking into
consideration surveillance, communication, IVM activ-
ities, intersectoral collaboration, and evaluation. The
activation of the plan should be based on the surveillance
data from the four possible basic indicators: mosquitoes,
birds, horses and humans. The main parameters to be
considered are: the level of virus activity in the area
estimated by the infection rate in Culex mosquitoes, the
percentage viremic birds, the equine cases, or recent sero-
conversions in sentinel birds or equines; the seasonal
period when WNV activity is first detected since the early-
season detection of WNV activity appears to be correlated
with increased risk of human cases later in the season,
whereas late-season detection of WNV activity may not
indicate a real human risk. In this framework it is consid-
ered that the risk of tangential transmission exists when
the surveillance activities show an increase in the circula-
tion of the virus. The complex epidemiology of WNV
infections requires that the surveillance activities are well
coordinated and progressively improved based on field
evidence and proper evaluation. A baseline scheme to
assist an evidence based decision making process is
depicted below. Difficulties in early estimation of the out-
break size in time and space complicates the implementa-
tion of adapted vector control measures, hence the need
to elaborate models to achieve a more precise epidemio-
logical forecast, allowing more effective and cost-benefit
appropriate decisions (Table 3).Conclusions
Most of the available data on WNV vector control
methods refer to North America, where, following the
introduction of the virus in 1999 and its rapid spread
through the country, an impressive amount of scientific
investigation as well as organized plans and implementa-
tion of vector control activities have been developed.
The reason why such an effort has never been made in
Europe has obviously come from the smaller impact the
WNV infection had on public health, with sporadic
incursions in sensitive areas and long periods of silence
and non-evident circulation. This situation seems to
have changed recently with several EU countries affected
in consecutive years. The US experience showed that,
when applied with appropriate methodologies and
resources, vector control measures such as adult control
may reduce the outbreak size. Multiple sequential treat-
ments may be necessary to reduce Culex female density
to a level where reduction of WNV infection may be
observed. If a large area is involved it becomes quite
difficult to organize an effective adult control program
using ground application only. The real effectiveness of
mosquito larval control in preventing or reducing the
risk for WNV human cases is a logical assumption but
remains to be demonstrated. While preferable to adult
control from the environmental points of view, larval
control might not be as effective as expected due to
density dependent phenomena and because it has no
influence on longevity of infective mosquito females.
Based on the available evidence an overview of the use
of the currently existing vector control methods is
presented in Table 1. Further studies are needed in the
EU to assess the value of each method to prevent and
control outbreaks of WNV infection and to assess the
best use in time and space (e.g. by the identification of
hot spot areas particularly favourable for the WNV
amplification early in the season). The proposed vector
control decision making process, in line with ECDC’s
West Nile risk assessment tool [107], aims at supporting
the rational choice of the control methods but warrants
further validation and refinement based on experiences
from outbreak control.
The extrapolation of information produced in North
America to Europe might be limited because of the
seemingly lower level of WNV transmission in the
European region probably due to the long-time exposure
of wild bird populations resulting in an ecosystem that is
less suitable for large outbreaks. Additionally, the diversity
of the susceptible bird fauna and of the vector species
involved in the enzootic and tangential transmission
in Europe makes WNV transmission remarkably different
with the US. Aerial insecticide applications being largely
adopted in the US are basically not allowed in the EU.
Hence, the cost-benefit of vector control in the US






Predisposed 1 Unknown Ecological condition suitable to WNV
circulation AND past evidences of
WNV circulation
Consider drafting WNV preparedness plan
Imperilled 2 Unknown Ecological condition suitable to
WNV circulation
Develop WNV preparedness plan, including
surveillance activities and an integrated vector
control plan
AND past evidences of WNV circulation Allocate resources necessary to enable
emergency response
Implement larval control as part of the
integrated vector control in case of WNV
circulation in previous year
Imperilled 3a Low Current surveillance findings (i.e. mosquito
or birds screening) indicating WNV epizootic
activity in the area, in the second part of
the season (August-September-October)
As in risk level 2
AND Implement public education programs
focused on risk potential, personal protection,
and emphasizing residential source reduction
Vector control focuses on larval control
Imperilled 3b Low to moderate Current surveillance findings (i.e. mosquito
or birds screening) indicating WNV
epizootic activity in the area, in the first
part of the season (May-June-July)
As in risk level 3a
AND increase entomological and bird surveillance
AND increase effort for public information on
personal protection and continued source reduction
AND If surveillance indicates virus circulation is
increasing initiate ground adult control in areas at
high risk for humans or in hot spot sites (if known)
Imperilled 4 High WNV specific IgM detected in local non
vaccinated horse(s) or WNV isolated
from local horse.
As in risk level 3b
If surveillance indicates virus circulation is increasing
initiate ground adult control in areas at high risk for
humans or in hot spot sites (if known)
Affected 5 ongoing outbreak,
uncertainty about size
at least one human case detected
(i.e. probable or confirmed human case
according to EU case definition)
Response as in level 4
AND intensify ground adult mosquito control with
multiple applications in areas of high risk of human cases
AND enhance risk communication
AND monitor efficacy of spraying on target mosquito
populations
AND in case a large area is involved coordinate the
program by an emergency unit with all authorities
involved
1Nomenclature according to [106].
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a careful specific evaluation. Therefore, there is an urgent
need to analyse the European experiences on the preven-
tion and control of outbreaks of WNV infection in order
to optimize resources while keeping the risk of acquiring
the infection at an acceptable level.
To be effective, vector control programs require a
strong organisational backbone and co-ordination
between the different stakeholders from the central to the
community level relying on a previously defined plan,
skilled technicians and operators, appropriate equipment,
and sufficient financial resources. The permanent allo-
cations of resources on an issue which is largely
unpredictable in space and time, with elapsing periods
between outbreaks that may last for years, could bedifficult to sustain and justify but is needed to develop
proper preparedness and response activities.Abbreviations
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